Hye-Jung Kim

Company: Genentech

Job title: Distinguished Scientist

Seminars:

CD8 Treg Control of Antibody Response 2:30 pm

CD8 Treg target pathogenic CD4 T helper cells through recognition of MHC-E/peptide Identification of TCRs expressed by CD8 Treg leads to understanding of CD8 Treg development Peptide-based approach allows CD8 Treg expansion and inhibition of Tfh-driven antibody responsesRead more

day: Treg Fundamental Biology Bootcamp Day